FDA Adverse Event Malfunction Summary report: N

ACTIVA PC+S

MDR report key: 8055337 · Received November 9, 2018

Report

Report Number
3004209178-2018-25092
Event Type
Malfunction
Date Received
November 9, 2018
Date of Event
November 1, 2018
Report Date
January 9, 2019
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
MHY
PMA / PMN Number
P960009
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

MODEL 37604 ACTIVA PC+S IS NOT A COMMERCIALLY MARKETED DEVICE, BUT IS SIMILAR TO MARKETED DEVICES AND THEREFORE IS REPORTABLE FOR MALFUNCTION. MHY AND P960009 ENTERED, AS THE DEVICE WAS IMPLANTED FOR ESSENTIAL TREMOR. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED FROM A HEALTH CARE PROVIDER (HCP) OF A CLINICAL STUDY VIA A MANUFACTURER REPRESENTATIVE (REP) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR (INS) FOR ESSENTIAL TREMOR. THE INS COULD NOT BE INTERROGATED. THE EVENT OCCURRED AFTER PREVIEWING RECORDINGS ON THE SENSING TABLET, STARTING A DOWNLOAD OF ALL THE DATE (SINGLE RUN), THE INS WAS ACCIDENTALLY INTERROGATED WITH THE PATIENT PROGRAMMER DURING THE DOWNLOAD SESSION, AND THE INS "LOCKED UP" IN UNDEFINED STATUS. THE INS COULD NOT BE INTERROGATED WITH THE SENSING TABLET, STIMULATION PROGRAMMER, NOR THE CLINICIAN PROGRAMMER. THE REP EXPLAINED HOW TO PERFORM A HARD POWER ON RESET (POR) ON THE INS, WHICH RESOLVED THE EVENT. NO MEDICAL SYMPTOMS WERE REPORTED. NO FURTHER COMPLICATIONS ARE ANTICIPATED.

Description of Event or Problem · 1

NO ADDITIONAL INFORMATION WAS RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
895312 ACTIVA PC+S STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC PUERTO RICO OPERATIONS CO. 37604

Patients

Seq Age Sex Outcome Treatment
1 77 YR